Cytokines in aortic dissection
T Zeng, L Shi, Q Ji, Y Shi, Y Huang, YU Liu, J Gan… - Clinica chimica acta, 2018 - Elsevier
Aortic dissection (AD) is one of the most dangerous forms of vascular disease, characterized
by endometrial rupture and intramural hematoma formation. Generally, the pathological …
by endometrial rupture and intramural hematoma formation. Generally, the pathological …
Targeted proteomic analysis of patients with ascending thoracic aortic aneurysm
A Daskalopoulou, SG Giotaki, K Toli, A Minia, V Pliaka… - Biomedicines, 2023 - mdpi.com
Background: There is a need for clinical markers to aid in the detection of individuals at risk
of harboring an ascending thoracic aneurysm (ATAA) or developing one in the future …
of harboring an ascending thoracic aneurysm (ATAA) or developing one in the future …
[HTML][HTML] CD40L promotes development of acute aortic dissection via induction of inflammation and impairment of endothelial cell function
L Han, L Dai, YF Zhao, HY Li, O Liu, F Lan… - Aging (Albany …, 2018 - ncbi.nlm.nih.gov
Acute aortic dissection is one of the most lethal cardiovascular disease. The major
histopathological feature of AAD is medial degradation, especially breakdown of elastin and …
histopathological feature of AAD is medial degradation, especially breakdown of elastin and …
The Potential Protective Role of FBN1 Deficiency-induced miRNA-146b-5p in Aneurysm Progression in Marfan's Syndrome.
D Hemani - 2023 - search.proquest.com
Abstract Fibrillin (FBN1), a glycoprotein, is essential for the formation of elastic fibers in the
ECM. FBN1 mutations cause Marfan syndrome. The FBN1 Q2467X nonsense mutation was …
ECM. FBN1 mutations cause Marfan syndrome. The FBN1 Q2467X nonsense mutation was …
Molecular mechanisms of thoracic aortic aneurysm in Marfan Syndrome
CX Dong - 2023 - ses.library.usyd.edu.au
Background: Marfan Syndrome (MFS) is a monogenic multisystem disorder resulting from
mutations in fibrillin-1, resulting in thoracic aortic aneurysm. Currently, effective treatments …
mutations in fibrillin-1, resulting in thoracic aortic aneurysm. Currently, effective treatments …